SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells

PURPOSE: We previously demonstrated an association between decreased SMAD4 expression and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to further elucidate the clinical relevance of SMAD4 loss in HNSCC. EXPERIMENTAL DESIGN: SMAD4 expression was...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Ozawa, Hiroyuki, Ranaweera, Ruchira, Izumchenko, Evgeny, Makarev, Eugene, Zhavoronkov, Alex, Fertig, Elana J., Howard, Jason D., Markovic, Ana, Bedi, Atul, Ravi, Rajani, Perez, Jimena, Le, Quynh-Thu, Kong, Christina S., Jordan, Richard C., Wang, Hao, Kang, Hyunseok, Quon, Harry, Sidransky, David, Chung, Christine H.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078415/
https://ncbi.nlm.nih.gov/pubmed/28522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1686
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker